In the present study, our results revealed that PSPC effectively attenuated hepatocyte apoptosis by restoring the NAD+ depletion-mediated SirT1 loss, thereby suppressing p53-apoptotic pathway and enhancing Akt survival pathway, ultimately improving NAFLD. Here, TP53 is linked to metabolic dysfunction-associated steatotic liver disease.